Metabolic Effects of Steroids in Obese Men

Status unconfirmed · Not applicable

Conditions studied: Obesity, Insulin Resistance

In brief

Subjects will be randomized into 4 study groups: 1. Placebo; 2. Anastrazole and Testosterone; 3. Dutasteride and Testosterone; and 4. Testosterone only. A 2 step euglycemic clamp, body composition by dual X-ray absorptiometry scan, hormone and lipid assays will be performed to monitor metabolic effects of each treatment group. We hypothesize that increasing testosterone levels would increase lean mass, decrease fat mass and improve insulin sensitivity. We further hypothesize that improvements in the metabolic profile would decrease with anastrazole and improve with dutasteride, given in conjunction with T administration.

Key facts

Study ID
NCT00983554
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
People needed
57
Starts
2005-06-01
Expected to finish
2009-10-01
Last updated by the study team
2011-03-16

Who can join

Age: 24 and older, up to 51. Sex: male. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.